G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $75 | -100.0% | 13,856 | -82.4% | 0.00% | -92.3% |
| Q3 2022 | $986,000 | +1692.7% | 78,938 | +613.2% | 0.01% | +1200.0% |
| Q2 2022 | $55,000 | -72.4% | 11,068 | -57.8% | 0.00% | -66.7% |
| Q1 2022 | $199,000 | -11.6% | 26,207 | +19.1% | 0.00% | +50.0% |
| Q4 2021 | $225,000 | -52.3% | 22,007 | -37.4% | 0.00% | -66.7% |
| Q3 2021 | $472,000 | -11.3% | 35,174 | +19.0% | 0.01% | +20.0% |
| Q4 2020 | $532,000 | +0.2% | 29,565 | -35.7% | 0.01% | -54.5% |
| Q3 2020 | $531,000 | -35.4% | 45,962 | +35.6% | 0.01% | -47.6% |
| Q2 2020 | $822,000 | +295.2% | 33,887 | +270.5% | 0.02% | +200.0% |
| Q3 2019 | $208,000 | – | 9,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |